Triple-Negative Breast Cancer Treatment: KEYTRUDA (Pembrolizumab) Patient Guide

Is Keytruda (pembrolizumab) really a game changer for TNBC? In this video, we explain in clear, simple terms how Keytruda works, who benefits from it, and why it has become an important option for TNBC. ⭐️ Get your personalized Yerbba Report at https://www.yerbba.com/ Use code YOUTUBE15 when you sign-up. We cover: • How Keytruda “unmasks” cancer cells so your immune system can attack • Why it’s used specifically for triple-negative breast cancer • How it improves response before surgery and outcomes after surgery • When it’s used in metastatic TNBC • What the KEYNOTE22 trials showed about survival • How it’s given and what side effects to watch for References 1. Keynote Trials: https://www.nejm.org/doi/full/10.1056... Connect With Yerbba! INSTAGRAM:   / yerbba   FACEBOOK:   / yerbba.breast.cancer   BLOG: https://www.yerbba.com/blog Chapters 0:00 What Is Keytruda? 1:36 Who’s it For? 2:27 Early-Stage TNBC 3:17 Metastatic TNBC 3:30 Keynote Trials 4:29 How is it Given? 5:35 Side Effects 6:46 Recap Disclaimer: Yerbba YouTube videos are for informational purposes only, do not constitute medical advice, and are not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your medical team, mental health professional, or other qualified health provider with any questions you may have regarding your medical condition.